HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Lamonica Selected Research

bectumomab

12/2002Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Lamonica Research Topics

Disease

2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2002 - 07/2001
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2015
1Disease Progression
12/2015
1Metabolic Bone Diseases (Osteopenia)
02/2008
1Osteonecrosis (Kienbock's Disease)
02/2008
1Osteoporosis
02/2008
1Neoplasms (Cancer)
12/2002
1Lymphoma (Lymphomas)
12/2002

Drug/Important Bio-Agent (IBA)

1Bendamustine HydrochlorideFDA Link
12/2015
1ibrutinibIBA
12/2015
1Rituximab (Mabthera)FDA Link
12/2015
1Diphosphonates (Bisphosphonates)IBA
02/2008
1Immunoglobulin FragmentsIBA
12/2002
1bectumomabIBA
12/2002
1ibritumomab tiuxetan (Zevalin)FDA Link
07/2001

Therapy/Procedure

2Radioimmunotherapy
12/2002 - 07/2001
1Salvage Therapy
12/2015
1Stem Cell Transplantation
02/2008
1Therapeutics
02/2008